Member Info for ratcliffewriter

Well I did say 'I'm sure there will be a simple reason for it'. Are they just conforming to standard practice maybe. At least we now know when one more RNS will be appearing!

I'm sure there will be a simple reason for it, but why put out an RNS saying when the results are to be published, something that will just generate another RNS? All previous years as far as I can see they have just had the RNS when the results come out. Any ideas anyone? (as long as they aren't wildly speculative doom-laden works of fiction as of old)

Some big names there - as you say, grass not growing under Scancell's corporate feet, of that I am quite sure.

I have to admit that with so much going on in Scancell, in a way I would love to see more newsflow rather than less because I want to hear the very latest stage with every development. On the other hand I wonder if long term watchers of the company have got a bit too used to being spoonfed with updates, and that which could be more significant news is often dulled by being too expected. For example the progress of the combination trial - we were all waiting for the IND submission, then the approval, then the inevitable start of the trial itself. If the IND was not mentioned and an RNS popped up out of the blue for the start of the trial, it gives a much bigger 'step up' when it hits rather than everyone just saying 'yup, but I was expecting that a month ago.' This could (IMO only, as with all of this post) also have a better effect on boosting the share price in response to significant events, rather than every event being a long-expected thing with consequently reduced publicity and impact. Consider what the market reaction could have been if the survival percentages and times of the SCIB1 trial had been kept under wraps until several years had elapsed and then put out in a bigger publicity push. Ever longer SCIB1 survival times became expected and mundane, and the biggest reaction was a negative one when a patient died. Survival 'well beyond the established norms' (copyright K Flaherty) got little or no credit because we were all so well aware of it. I just wonder if there has been a change of tack in news management, because in terms of business-building and scientific interest Scancell is undeniably advancing apace - but we all know that already don't we? See what I mean....?

Novichok - free holiday in Wiltshire with every bottle.

....expectant boredom!

Always nice to see a day with more than a trickle of trades, and 250k in one hit is very nice. Still think C7 may be right that there may be a delayed sell to come, otherwise it would possibly have ticked up more.

Time for nom to put something on Sar I suspect. He's done sclp and Val but seems to be neglecting his usual third point on his rounds.

'Maybe somebody knows something', to quote a long-departed poster...

Jaffa, not Marfa ffs.

If I give you a Marfa cake you can sit on my knee and we can discuss whatever comes up.

They could just write 'soap dodger'. Or at least get someone from Social Services to write it for them.

Apologies if Ray, Chelsea Steve and I were making a meal of it.

I look on it as my first dividend from Scancell - two small sandwiches and a mushroom vol au vent. Hoping it will increase in the future. A pork pie would be nice.

Last AGM I managed to get to, I brought my own Jaffa Cakes.

They'll need to give the caterers some notice too, so they can prepare the buffet for shareholders. Or not.

From CRUK's own website regarding last year's awards - 'In 2017 with the generous support of our donors and The Dutch Cancer Society four remarkable Grand Challenge teams were funded – each receiving up to £20m over the next five years to take on some of the toughest challenges in cancer research.'
Up to 20 million each. So statistically that lowers the bare chances from one in ten to one in 2 and a half, but as has been pointed out Scancell's is the only immunotherapy project and has some huge names involved. I know it isn't a done deal until it is awarded, but I know what my money is on - literally and metaphorically

An just to keep admin and cynics happy, here's the link - https://www.cancerresearchuk.org/funding-for-researchers/how-we-deliver-research/grand-challenge-award/previously-funded-teams

Nom has posted on Val and here, just needs to post on SAR and he'll have done his usual round. Nice to see Inanaco's posts - knowledgeable and informative in massive quantities. Looking forward to near future and beyond.

Ruck - would you agree though that no pharma will stump up big cash until the scientists are well and truly interested?

Last warning...